Navigation Links
Cynosure Receives FDA Clearance for At-Home Device for the Treatment of Wrinkles
Date:7/18/2012

WESTFORD, Mass., July 18, 2012 /PRNewswire/ -- Cynosure, Inc. (NASDAQ: CYNO) today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market a home-use over the counter device for the treatment of facial wrinkles.  The device was developed in partnership with Unilever (NYSE: UL), a leading global consumer goods company. The device, which is indicated for the treatment of both periorbital and perioral wrinkles, is expected to be launched commercially by Unilever in 2013.

"FDA clearance of this device marks a significant milestone in our alliance with Unilever to develop light-based devices for the consumer market," said Michael Davin, Cynosure's President and Chief Executive Officer.  "Our strategic partnership with Unilever blends our expertise in developing market leading light-based technology that emphasizes patient safety and clinical results, with Unilever's unparalleled innovation, branded marketing and distribution."

According to the research firm Medical Insight, worldwide sales of home-use aesthetic devices are expected to grow at a compound annual rate of 12.3% from $740.4 million in 2011 to more than $1.3 billion in 2016.  In North America, Medical Insight estimates the home-use category is expected to grow by a compound annual rate of 12.1% from $451.6 million in 2011 to approximately $800 million by 2016.

Cynosure signed a multi-year funded cooperative development agreement with Unilever in June 2009 to develop and commercialize light-based devices targeting the home use personal care market. 

About Cynosure, Inc.Cynosure, Inc. develops and markets aesthetic treatment systems that are used by physicians and other practitioners to perform non-invasiv
'/>"/>

SOURCE Cynosure, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Somnetics Pioneering CPAP Device Receives the 2012 North American Frost & Sullivan Award for Product Differentiation Excellence
2. Discovery Labs Receives US Patent for Method to Promote Mucus Clearance with Pulmonary Surfactant
3. Beverly Hills Dentist, Dr. Zadeh, Receives 2011 Mastership Award from the Academy of General Dentistry
4. Par Formulations (Formerly Edict Pharmaceuticals) Receives First ANDA Approval
5. Integrity Life Sciences Receives CE Mark and ISO Certifications for the Integrity Spinal Care System Medical Device
6. Kimberly-Clark Health Care Receives FDA Clearance For KIMGUARD ONE-STEP Sterilization Wrap Portfolio With One-Year Maintenance Of Package Integrity And Amsco V-PRO maX (Flexible Cycle)
7. Dehaier Medical Receives Software Copyrights for Four Proprietary Technologies
8. Watsons Generic ARTHROTEC(R) Receives FDA Approval
9. Sofie Biosciences receives $1M Phase II SBIR grant from the DOE
10. Asthmapolis Receives FDA Clearance for Asthma Inhaler Sensor Technology and Accompanying Software System
11. Integrity Life Sciences Receives US FDA 510(k) Clearance for its Integrity Spinal Care System Medical Device
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... Since last month,s FBI shutdown of online ... the leading online black market for illegal drugs - ... offering of drugs and other illegal items.  New numbers ... succeed in lowering the numbers of drugs and illegal ... in August. But some new sites that have emerged ...
(Date:12/19/2014)... China separating membrane market has witnessed robust development ... years, albeit as a later starter. In 2012, the size ... approximated RMB12 billion, with the proportion worldwide soaring to 16.3%. ... membrane market will continue its growth rate by around 20% ... will jump to roughly RMB25 billion. An integrated ...
(Date:12/17/2014)... Revenue and earnings above the previous year - ... In the past 2013/14 fiscal year (ended 30 September ... 4.287 billion (last year: EUR 4.190 billion) despite unfavorable currency ... million. "Overall, 2013/14 was a successful fiscal year for the ... CEO of Carl Zeiss AG. "Thanks to our broad portfolio ...
Breaking Medicine Technology:Post Silk Road - Another Online Drug Den Now Dominates the DarkNet 2Post Silk Road - Another Online Drug Den Now Dominates the DarkNet 3Separation Membranes Market (Company, Country & Application) Research Reports for Global and Chinese Regions 2Separation Membranes Market (Company, Country & Application) Research Reports for Global and Chinese Regions 3ZEISS Asserts its Position in Difficult Environment 2
... 21 Advanced Life Sciences,Holdings, Inc. (Nasdaq: ... of its,collaboration with the National Institute of ... institute supporting biodefense,research, under which the NIAID ... late-stage antibiotic, as a treatment for,anthrax and ...
... By ... Year- End 2007, ... focused on discovering and,developing novel RNA interference-based therapeutics, announced today that,it ... at,Buffalo, Center for Hearing & Deafness, which is the Company,s primary ...
Cached Medicine Technology:Advanced Life Sciences Collaborates with U.S. Government to Study Cethromycin as Treatment for Anthrax and Other High-Priority Biodefense Agents 2Advanced Life Sciences Collaborates with U.S. Government to Study Cethromycin as Treatment for Anthrax and Other High-Priority Biodefense Agents 3Advanced Life Sciences Collaborates with U.S. Government to Study Cethromycin as Treatment for Anthrax and Other High-Priority Biodefense Agents 4Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss 2Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss 3Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss 4
(Date:12/19/2014)... Oshkosh, Wisconsin (PRWEB) December 19, 2014 ... country music performer is again returning to the stage ... joining her husband for concert performances, and the successful ... show was originally announced. , Visit Ticketability.com ... for the newly-announced Detroit shows at fair prices. , ...
(Date:12/19/2014)... in good shape seems to reduce your risk of high ... more than 57,000 Americans, including more than 35,000 with high ... Those in the poorest shape had a more than ... start of the study, compared to a 50 percent chance ... more than 8,000 people diagnosed with high blood pressure during ...
(Date:12/19/2014)... Randy Dotinga HealthDay ... -- Common painkillers, including ibuprofen, might slightly reduce your ... say. Use of ibuprofen (Advil, Motrin) and naproxen ... skin cancer by 15 percent, the researchers concluded after ... usually caused by sun exposure. These ...
(Date:12/17/2014)... While countless companies tempt patients to buy hCG ... of their purchase. Not only is the sale of hCG ... patients who buy hCG online are typically receiving products that ... real hCG present. Illegal internet hCG is typically manufactured outside ... and may contain unknown fillers that can pose very serious ...
(Date:12/17/2014)... 17, 2014 HeartMath® Inc., recognized ... stress, heart rate variability (HRV), heart coherence and ... extensive HRV databases and algorithms to chipset manufacturers ... enable HeartMath’s partners to offer its HRV solutions, ... as well as its normative HRV databases and ...
Breaking Medicine News(10 mins):Health News:Garth Brooks Tickets for Joe Louis Arena: Ticketability.com Becomes a Popular Destination for Discount Tickets for Garth Brooks’ Detroit Concerts Set for February 27-28 2Health News:Being Fit Keeps Blood Pressure in Check 2Health News:Common Painkillers May Help Prevent Certain Skin Cancers, Study Finds 2Health News:Common Painkillers May Help Prevent Certain Skin Cancers, Study Finds 3Health News:Diet Doc Reveals the Real Dangers for Those who Buy hCG Online 2Health News:Diet Doc Reveals the Real Dangers for Those who Buy hCG Online 3Health News:HeartMath® Inc.’s HRV Platform Solutions Available for Licensing 2Health News:HeartMath® Inc.’s HRV Platform Solutions Available for Licensing 3
... 14 (HealthDay News) -- Military veterans who attempt suicide are ... have an overall heightened risk of death from all causes, ... in BioMed Central Public Health , looked at the ... Veterans Affairs medical center for a suicide attempt between 1993 ...
... THURSDAY, July 14 (HealthDay News) -- Before the advent of ... information -- such as phone numbers and birthdays -- than you ... the brain just doesn,t remember information as well if the person ... people may remember, however, is where they need to ...
... part of the Target Safely initiative, the American Society for ... of a series of such papers, on the safe use ... oncology clinic. The executive summary of this white paper is ... (PRO), ASTRO,s clinical practice journal. The full text of the ...
... 14 July 2011 Bristol-Myers Squibb today announced that ... treatment of adult patients with previously-treated advanced melanoma. ... the treatment of patients with advanced melanoma in a ... England Journal of Medicine in June 2010.(1) Based ...
... Whether patients with type 2 diabetes mellitus benefit from ... levels through treatment ("intensive blood glucose control") remains an ... a benefit but also of potential harm. This is ... Institute for Quality and Efficiency in Health Care (IQWiG). ...
... , WEDNESDAY, July 13 (HealthDay News) -- A new study ... patients thinking that real and fake drugs were doing the ... had a much greater physical effect on their lungs. ... were breathing much better even if they hadn,t taken a ...
Cached Medicine News:Health News: Can You Google Your Memory? 2Health News: Can You Google Your Memory? 3Health News: Can You Google Your Memory? 4Health News:ASTRO publishes white paper on IMRT safety 2Health News:YERVOY (ipilimumab) approved for the treatment of previously treated advanced melanoma in the EU 2Health News:YERVOY (ipilimumab) approved for the treatment of previously treated advanced melanoma in the EU 3Health News:Benefit of blood glucose lowering to near-normal levels remains unclear 2Health News:Benefit of blood glucose lowering to near-normal levels remains unclear 3Health News:Delving Into the Mystery of Placebos 2Health News:Delving Into the Mystery of Placebos 3
The Clinac C family of accelerators are reliable, easy-to-use, flexible and cost-effective systems....
Based on the clinically proven ACS MULTI-LINK Stent, ULTRA is a coronary stent system specifically designed for use in larger vessels. This innovative system utilizes a unique stent pattern to give y...
The MULTI-LINK RX PENTA Coronary Stent Systems with new ACCESS-LINK Stent Design are indicated for improving coronary luminal diameter....
Take Performance to a Higher Level....
Medicine Products: